GLYSTAR Trademark

Trademark Overview


On Thursday, March 7, 2002, a trademark application was filed for GLYSTAR with the United States Patent and Trademark Office. The USPTO has given the GLYSTAR trademark a serial number of 78113110. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, August 13, 2006. This trademark is owned by Glaxo Group Limited. The GLYSTAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of antiviral and infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations

General Information


Serial Number78113110
Word MarkGLYSTAR
Filing DateThursday, March 7, 2002
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSunday, August 13, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 20, 2003

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of antiviral and infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 13, 2002
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB6 ONN
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB6 ONN
GB

Trademark Events


Event DateEvent Description
Wednesday, October 18, 2006ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Wednesday, October 18, 2006ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 21, 2006EXTENSION 5 GRANTED
Wednesday, January 25, 2006EXTENSION 5 FILED
Wednesday, January 25, 2006TEAS EXTENSION RECEIVED
Friday, July 29, 2005EXTENSION 4 GRANTED
Monday, July 25, 2005EXTENSION 4 FILED
Monday, July 25, 2005TEAS EXTENSION RECEIVED
Wednesday, April 13, 2005EXTENSION 3 GRANTED
Thursday, January 13, 2005EXTENSION 3 FILED
Sunday, August 15, 2004EXTENSION 2 GRANTED
Wednesday, July 14, 2004EXTENSION 2 FILED
Monday, March 1, 2004EXTENSION 1 GRANTED
Thursday, February 12, 2004EXTENSION 1 FILED
Friday, February 4, 2005PETITION TO REVIVE-GRANTED
Wednesday, July 14, 2004PETITION TO REVIVE-RECEIVED
Thursday, January 13, 2005TEAS EXTENSION RECEIVED
Wednesday, July 14, 2004PAPER RECEIVED
Monday, June 7, 2004ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 12, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 20, 2003PUBLISHED FOR OPPOSITION
Wednesday, April 30, 2003NOTICE OF PUBLICATION
Tuesday, March 4, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 30, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 30, 2003PAPER RECEIVED
Thursday, October 3, 2002NON-FINAL ACTION MAILED
Thursday, September 5, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 5, 2002PAPER RECEIVED
Monday, June 17, 2002NON-FINAL ACTION MAILED
Monday, June 17, 2002ASSIGNED TO EXAMINER